Forian

Forian ROE

Delisted

The Return on Equity (ROE) of Forian (FORA) as of Oct 24, 2026 is -12.55 %. In the previous year, Return on Equity (ROE) was 42.45 % — a change of -129.56% (lower).

ROE

-12.55 %

YoY

-129.56%

Last updated:

In 2024, Forian's return on equity (ROE) was -12.55 %, a -129.56% increase from the 42.45 % ROE in the previous year.

The Forian ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2017
-6,088.89 USD
Jan 1, 2018
-53.18 USD
Jan 1, 2019
-14.70 USD
Jan 1, 2020
-44.19 USD
Jan 1, 2021
-105.48 USD
Jan 1, 2022
-209.10 USD
Jan 1, 2023
42.45 USD
Jan 1, 2024
-12.55 USD
The Forian ROE history
YEARROEYoY
-12.55 %-129.56%
42.45 %-120.30%
-209.10 %+98.23%
-105.48 %+138.71%
-44.19 %+200.51%
-14.70 %-72.35%
-53.18 %-99.13%
-6,088.89 %-469.02%
1,650.00 %-1,389.06%
-128.00 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Forian Stock analysis

What does Forian do? Forian, Inc. generates revenue through its Information and Software segment, which licenses data management and analytics products to healthcare life sciences, payer, and provider customers. The Services segment offers implementation, support, and training services on a contractual basis to these same segments. The Other segment provides security and marketing services, primarily through its security and marketing operations. The company's data management solution organizes, normalizes, standardizes, integrates, enhances, and publishes transactional information for customers across traditional and emerging healthcare sectors. Patient registries solutions help clients understand disease progression, treatment protocols, and therapeutic effectiveness through data-driven insights. Forian's customers within the healthcare payer and provider segments purchase its data management capabilities and analytics tools to optimize operational, clinical, and financial performance. The life sciences segment uses its information and software products for research and development purposes. The company's services include implementation, support, and training, which are contracted by customers seeking to integrate Forian's solutions into their workflows. Security and marketing services in the Other segment are provided to support broader business operations. The Information and Software segment licenses products that include data management and analytics solutions tailored for healthcare organizations. Services segment contracts focus on implementation, support, and training for customers using these solutions. The Other segment's security and marketing services are secondary operations that complement the primary business model. Forian's offerings enable healthcare organizations to measure performance across clinical, operational, and financial dimensions through standardized data processes. Forian is one of the most popular companies on Eulerpool.

ROE Details

Decoding Forian's Return on Equity (ROE)

Forian's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Forian's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Forian's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Forian’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Forian stock

Return on Equity (ROE) of Forian is -12.55 % in 2024.

Return on Equity (ROE) of Forian changed from 42.45 % to -12.55 %, representing a -129.56% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Forian since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Forian with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Forian

All Key Metrics — Forian